Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias
Gettes, L.S.
Cardiovascular Clinics 2(2): 211-237
1970
ISSN/ISBN: 0069-0384 PMID: 4149974 Document Number: 29338
Document emailed within 1 workday
Related Documents
Batlle, F.; Carreño, C.A.; Guetta, N.J.; Vassolo, E.; Bertolasi, C.A. 1970: Treatment of cardiac arrhythmias using a beta adrenergic receptor blocking drug Prensa Medica Argentina 57(38): 1801-1808Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Benchimol, A.B.; Saad, E.A. 1970: Beta adrenergic receptor blockaders in the treatment of cardiac arrhythmias Hospital (Rio de Janeiro) 78(1): 1-33
Slawin, S. 1973: Beta adrenergic blocking drugs Harefuah 85(4): 178-183
Walters, L.; Dormehl, I.; Goosen, D.J.; Avenant, J.C.; Du Plessis, M.; Jacobs, N.; Schoeman, H.S. 1983: Beta-adrenergic blocking drugs and renal function South African Medical Journal 64(15): 572-573
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Madan, B.R.; Gupta, R.S. 1970: Effect of adrenergic beta receptor blocking agents on cardiac output Indian Heart Journal 22(2): 70-72
Wayne, V.S.; Harper, R.W.; Laufer, E.; Federman, J.; Anderson, S.T.; Pitt, A. 1982: Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases Australian and New Zealand Journal of Medicine 12(4): 285-289
Mills, T.A.; Kawji, M.M.; Cataldo, V.D.; Pappas, N.D.; O'Meallie, L.P.; Breaux, D.M.; Glancy, D.L. 2004: Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 156(6): 327-331
Atsmon, A.; Blum, I. 1978: Beta-adrenergic blocking drugs in psychiatry: present status, future approaches and research L'Encephale 4(2): 173-186
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Merin, R.G. 1972: Anesthetic management problems posed by therapeutic advances: 3. Beta-adrenergic blocking drugs Anesthesia and Analgesia 51(4): 617-624
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175
Singh, B.N. 1973: Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias New Zealand Medical Journal 78(504): 482-486
Duggan, M.A.; Court, J.B. 1981: A proposed mechanism of production of the autoimmune and lymphoproliferative side-effects of beta-adrenergic-site-blocking drugs and hydantoin anticonvulsants Annals of Clinical Research 13(6): 406-418
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Frick, M.H.; Hartikainen, M.; Pörsti, P. 1978: Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol Annals of Clinical Research 10(2): 105-106
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317